Structure-activity relationships in the cyproheptadine series. 1965

E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden

UI MeSH Term Description Entries
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
November 1993, Journal of pharmaceutical sciences,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
September 2002, Current medicinal chemistry,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
May 1974, Indian journal of experimental biology,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
March 2000, The Journal of antibiotics,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
June 1979, Journal of pharmaceutical sciences,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
January 1976, Experientia. Supplementum,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
January 1977, Journal of medicinal chemistry,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
February 1960, Antibiotics & chemotherapy (Northfield, Ill.),
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
March 1988, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
E L Engelhardt, and H C Zell, and W S Saari, and M E Christy, and C D Colton, and C A Stone, and J M Stavorski, and H C Wenger, and C T Ludden
September 1965, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!